首页> 外文期刊>Biochimica et Biophysica Acta. General Subjects >Human pancreatic lipase-related protein 2: Tissular localization along the digestive tract and quantification in pancreatic juice using a specific ELISA
【24h】

Human pancreatic lipase-related protein 2: Tissular localization along the digestive tract and quantification in pancreatic juice using a specific ELISA

机译:人胰脂肪酶相关蛋白2:沿消化道的纵行定位,并使用特异性ELISA定量胰液

获取原文
获取原文并翻译 | 示例
           

摘要

Human pancreatic lipase-related protein 2 (HPLRP2) was previously found to be secreted by the exocrine pancreas. HPLRP2 shows a high level of activity on galactolipids, and might be involved in the digestion of these common vegetable lipids. Specific antibodies were raised in rabbits using a synthetic HPLRP2 peptide selected for its weak amino acid homology with the corresponding peptides of classical human pancreatic lipase (HPL) and human pancreatic lipase-related protein 1 (HPLRP1). ELISA and Western blotting data showed that these antibodies did not react with HPL or HPLRP1. Various tissues from the digestive tract were subjected to Western blotting analysis with the specific antipeptide HPLRP2 antibody and the expression of HPLRP2 was detected in the pancreas and colon. An ELISA was developed for specifically measuring the HPLRP2 levels in pure pancreatic juice. This procedure was performed using the anti-peptide HPLRP2 antibody as the captor antibody and a biotinylated anti-HPLRP2 polyclonal antibody as the detector antibody. The lowest HPLRP2 quantification limit was found to be 50 mu g/L and the reference range for the present assay was 50 mu g-500 mu g/L. HPL and HPLRP2 levels were measured using specific ELISAs in pancreatic juice from patients with and without pancreatic disorders. Patients with chronic calcifying pancreatitis (CCP) had significantly lower levels of both HPL and HPLRP2 than the controls subjects. The mean HPLRP2 to HPL ratio was estimated to be 28.30% (w/w) and 23.96% (w/w) in controls subjects and CCP patients, respectively, and the difference was not significant. The levels of HPL and HPLRP2 are therefore similarly reduced in both healthy patients and CCP patients. (c) 2006 Elsevier B.V. All rights reserved.
机译:先前发现人胰腺脂肪酶相关蛋白2(HPLRP2)由外分泌胰腺分泌。 HPLRP2对半乳糖脂具有很高的活性,可能与这些常见植物脂质的消化有关。使用合成的HPLRP2肽在兔中产生特异性抗体,该肽的选择具有弱氨基酸同源性,该肽与经典人胰脂肪酶(HPL)和人胰脂肪酶相关蛋白1(HPLRP1)的相应肽具有同源性。 ELISA和蛋白质印迹数据表明,这些抗体不与HPL或HPLRP1反应。用特异性抗肽HPLRP2抗体对消化道的各种组织进行蛋白质印迹分析,并在胰腺和结肠中检测到HPLRP2的表达。已开发出一种ELISA,用于专门测量纯胰液中HPLRP2的水平。使用抗肽HPLRP2抗体作为捕获抗体,并使用生物素化的抗HPLRP2多克隆抗体作为检测器抗体进行此过程。发现最低HPLRP2定量限为50μg / L,本测定的参考范围为50μg-500μg / L。使用特异的ELISA法测量患有和不患有胰腺疾病的患者的胰液中的HPL和HPLRP2水平。慢性钙化性胰腺炎(CCP)患者的HPL和HPLRP2水平均明显低于对照组。对照组和CCP患者的平均HPLRP2与HPL比率分别估计为28.30%(w / w)和23.96%(w / w),差异不显着。因此,在健康患者和CCP患者中,HPL和HPLRP2的含量均降低。 (c)2006 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号